Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation
Omid Tavassoly(Montreal Neurological Institute and Hospital), Edward A. Fon(Montreal Neurological Institute and Hospital)
Cited by 26
Related Papers
Ubiquitin is phosphorylated by PINK1 to activate parkin
|Nature|2014|1.5k
<scp>USP</scp> 8 regulates mitophagy by removing <scp>K</scp> 6‐linked ubiquitin conjugates from parkin
|The EMBO Journal|2014|367
<i>SMPD1</i> mutations, activity, and α‐synuclein accumulation in Parkinson's disease
|Movement Disorders|2019|117
Genetic, Structural, and Functional Evidence Link <i>TMEM175</i> to Synucleinopathies
|Annals of Neurology|2019|108
Fine‐Mapping of <i>SNCA</i> in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies
|Annals of Neurology|2020|66